<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33468103</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).</ArticleTitle><Pagination><StartPage>13</StartPage><MedlinePgn>13</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-020-01885-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Much progress has been made in mapping genetic abnormalities linked to amyotrophic lateral sclerosis (ALS), but the majority of cases still present with no known underlying cause. Furthermore, even in families with a shared genetic abnormality there is significant phenotypic variability, suggesting that non-genetic elements may modify pathogenesis. Identification of such disease-modifiers is important as they might represent new therapeutic targets. A growing body of research has begun to shed light on the role played by the gut microbiome in health and disease with a number of studies linking abnormalities to ALS.</AbstractText><AbstractText Label="MAIN BODY">The microbiome refers to the genes belonging to the myriad different microorganisms that live within and upon us, collectively known as the microbiota. Most of these microbes are found in the intestines, where they play important roles in digestion and the generation of key metabolites including neurotransmitters. The gut microbiota is an important aspect of the environment in which our bodies operate and inter-individual differences may be key to explaining the different disease outcomes seen in ALS. Work has begun to investigate animal models of the disease, and the gut microbiomes of people living with ALS, revealing changes in the microbial communities of these groups. The current body of knowledge will be summarised in this review. Advances in microbiome sequencing methods will be highlighted, as their improved resolution now enables researchers to further explore differences at a functional level. Proposed mechanisms connecting the gut microbiome to neurodegeneration will also be considered, including direct effects via metabolites released into the host circulation and indirect effects on bioavailability of nutrients and even medications.</AbstractText><AbstractText Label="CONCLUSION">Profiling of the gut microbiome has the potential to add an environmental component to rapidly advancing studies of ALS genetics and move research a step further towards personalised medicine for this disease. Moreover, should compelling evidence of upstream neurotoxicity or neuroprotection initiated by gut microbiota emerge, modification of the microbiome will represent a potential new avenue for disease modifying therapies. For an intractable condition with few current therapeutic options, further research into the ALS microbiome is of crucial importance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Boddy</LastName><ForeName>Sarah L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Giovannelli</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sassani</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper-Knock</LastName><ForeName>Johnathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snyder</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Eran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elinav</LastName><ForeName>Eran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cancer-Microbiome Research, DKFZ, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Lynne A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Centre for Behavioural Science and Applied Psychology, Sheffield Hallam University, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDermott</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK. c.j.mcdermott@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1U54DE02378901</GrantID><Agency>NIH Human Microbiome Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023421" MajorTopicYN="N">Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Disease modifiers</Keyword><Keyword MajorTopicYN="N">Microbial</Keyword><Keyword MajorTopicYN="N">Microbial metabolites</Keyword><Keyword MajorTopicYN="N">Microbiome</Keyword></KeywordList><CoiStatement>The authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33468103</ArticleId><ArticleId IdType="pmc">PMC7816375</ArticleId><ArticleId IdType="doi">10.1186/s12916-020-01885-3</ArticleId><ArticleId IdType="pii">10.1186/s12916-020-01885-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z-Y, Liu M-S, Li X-G, Cui L-Y. Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression. Ann Transl Med. 2015;3 https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4583590/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4583590</ArticleId><ArticleId IdType="pubmed">26488017</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Shaw PJ, Kirby J. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol. 2014;127:333&#x2013;345. doi: 10.1007/s00401-014-1251-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1251-9</ArticleId><ArticleId IdType="pmc">PMC3925297</ArticleId><ArticleId IdType="pubmed">24493408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mazzini L, D&#x2019;Alfonso S, Corrado L, Canosa A, Moglia C, et al. The multistep hypothesis of ALS revisited. Neurology. 2018;91:e635&#x2013;e642. doi: 10.1212/wnl.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew AS, Caller TA, Tandan R, Duell EJ, Henegan PL, Field NC, et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener Dis. 2017;17:110&#x2013;116. doi: 10.1159/000453359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453359</ArticleId><ArticleId IdType="pmc">PMC5383428</ArticleId><ArticleId IdType="pubmed">28122372</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes. Neurology. 2003;61:387&#x2013;389. doi: 10.1212/01.wnl.0000078320.18564.9f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000078320.18564.9f</ArticleId><ArticleId IdType="pubmed">12913204</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Murch SJ, Cox PA. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 2006;106:97&#x2013;104. doi: 10.1016/j.jep.2005.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2005.12.032</ArticleId><ArticleId IdType="pubmed">16457975</ArticleId></ArticleIdList></Reference><Reference><Citation>Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev. 2015;37:55&#x2013;70. doi: 10.1093/epirev/mxu001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/epirev/mxu001</ArticleId><ArticleId IdType="pmc">PMC4325667</ArticleId><ArticleId IdType="pubmed">25365170</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, Quinlan P, Ye W, Barber MK, Umbach DM, Sandler DP, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect. 2009;117:1387&#x2013;1392. doi: 10.1289/ehp.0900580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.0900580</ArticleId><ArticleId IdType="pmc">PMC2737014</ArticleId><ArticleId IdType="pubmed">19750102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Jenkins T, Shaw PJ. Clinical and molecular aspects of motor neuron disease. Morgan &amp; Claypool Life Sciences: Biota Publishing; 2013. 10.4199/C00093ED1V01Y201309GMM004.</Citation></Reference><Reference><Citation>Su F-C, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:803&#x2013;811. doi: 10.1001/jamaneurol.2016.0594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.0594</ArticleId><ArticleId IdType="pmc">PMC5032145</ArticleId><ArticleId IdType="pubmed">27159543</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59&#x2013;65. doi: 10.1038/nature08821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08821</ArticleId><ArticleId IdType="pmc">PMC3779803</ArticleId><ArticleId IdType="pubmed">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell JS, Spencer JI, Yates RL, Yee SA, Jacobs BM, DeLuca GC. Invited Review: From nose to gut &#x2013; the role of the microbiome in neurological disease. Neuropathol Appl Neurobiol. 2019;45:195&#x2013;215. doi: 10.1111/nan.12520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12520</ArticleId><ArticleId IdType="pubmed">30298527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Yi J, Zhang Y-G, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3:e12356. doi: 10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-G, Wu S, Yi J, Xia Y, Jin D, Zhou J, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Models Mech. 2020;13:dmm041947. doi: 10.1242/dmm.041947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.041947</ArticleId><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney MM, Ericsson AC, Lever TE. Effects of intraoperative vagal nerve stimulation on the gastrointestinal microbiome in a mouse model of amyotrophic lateral sclerosis. Comp Med. 2018;68:452&#x2013;460. doi: 10.30802/AALAS-CM-18-000039.</Citation><ArticleIdList><ArticleId IdType="doi">10.30802/AALAS-CM-18-000039</ArticleId><ArticleId IdType="pmc">PMC6310200</ArticleId><ArticleId IdType="pubmed">30424824</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Baker MC, Jackson JL, DeJesus-Hernandez M, Finch NA, Tian S, et al. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol Commun. 2019;7:150. doi: 10.1186/s40478-019-0797-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0797-0</ArticleId><ArticleId IdType="pmc">PMC6781370</ArticleId><ArticleId IdType="pubmed">31594549</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis. 2007;26:1&#x2013;13. doi: 10.1016/j.nbd.2006.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.12.015</ArticleId><ArticleId IdType="pubmed">17300945</ArticleId></ArticleIdList></Reference><Reference><Citation>Waring MJ, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov. 2015;14:475&#x2013;486. doi: 10.1038/nrd4609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4609</ArticleId><ArticleId IdType="pubmed">26091267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6:114&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3902221</ArticleId><ArticleId IdType="pubmed">24489990</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, et al. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016;7. 10.3389/fmicb.2016.01479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017;5:e13443. 10.14814/phy2.13443.</Citation></Reference><Reference><Citation>Zhai C-D, Zheng J-J, An B-C, Huang H-F, Tan Z-C. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis. Chin Med J. 2019;132:1815&#x2013;1822. doi: 10.1097/cm9.0000000000000351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/cm9.0000000000000351</ArticleId><ArticleId IdType="pmc">PMC6759115</ArticleId><ArticleId IdType="pubmed">31306225</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Hiergeist A, Adis C, Mayer B, Gessner A, Ludolph AC, et al. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132&#x2013;137. doi: 10.1016/j.neurobiolaging.2017.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D, Cionci NB, Baffoni L, Amoruso A, Pane M, et al. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18. 10.1186/s12916-020-01607-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, Restuadi R, McCrae AF, Van Eijk RP, Garton F, Henderson RD, Wray NR, McCombe PA, Steyn FJ. Progression and survival of patients with motor neuron disease relative to their fecal microbiota. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020;21:7&#x2013;8:549&#x2013;62. 10.1080/21678421.2020.1772825.</Citation><ArticleIdList><ArticleId IdType="pubmed">32643435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q, Shen J, Chen K, Zhou J, Liao Q, Lu K, et al. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep. 2020;10:12998. doi: 10.1038/s41598-020-69845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69845-8</ArticleId><ArticleId IdType="pmc">PMC7398913</ArticleId><ArticleId IdType="pubmed">32747678</ArticleId></ArticleIdList></Reference><Reference><Citation>Willing BP, Russell SL, Finlay BB. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol. 2011;9:233&#x2013;243. doi: 10.1038/nrmicro2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2536</ArticleId><ArticleId IdType="pubmed">21358670</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Zhan Y, Mariosa D, Larsson H, Almqvist C, Ingre C, et al. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2019;26:1355&#x2013;1361. doi: 10.1111/ene.13986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13986</ArticleId><ArticleId IdType="pubmed">31087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso R, Pisa D, Marina AI, Morato E, R&#xe1;bano A, Rodal I, et al. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Int J Biol Sci. 2015;11:546&#x2013;558. doi: 10.7150/ijbs.11084.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.11084</ArticleId><ArticleId IdType="pmc">PMC4400386</ArticleId><ArticleId IdType="pubmed">25892962</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso R, Pisa D, Carrasco L. Searching for bacteria in neural tissue from amyotrophic lateral sclerosis. Front Neurosci. 2019;13. 10.3389/fnins.2019.00171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6399391</ArticleId><ArticleId IdType="pubmed">30863279</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A, Matthias T, Aminov R. Potential effects of horizontal gene exchange in the human gut. Front Immunol. 2017;8:1630. doi: 10.3389/fimmu.2017.01630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01630</ArticleId><ArticleId IdType="pmc">PMC5711824</ArticleId><ArticleId IdType="pubmed">29230215</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Chen X, Skogerb&#xf8; G, Zhang P, Chen R, He S, et al. The human microbiome: a hot spot of microbial horizontal gene transfer. Genomics. 2012;100:265&#x2013;270. doi: 10.1016/j.ygeno.2012.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2012.07.012</ArticleId><ArticleId IdType="pubmed">22841660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitaraman R. Prokaryotic horizontal gene transfer within the human holobiont: ecological-evolutionary inferences, implications and possibilities. Microbiome. 2018;6:163. doi: 10.1186/s40168-018-0551-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-018-0551-z</ArticleId><ArticleId IdType="pmc">PMC6142633</ArticleId><ArticleId IdType="pubmed">30223892</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong H, Arif B, Caetano-Anoll&#xe9;s G, Kim KM, Nasir A. Horizontal gene transfer in human-associated microorganisms inferred by phylogenetic reconstruction and reconciliation. Sci Rep. 2019;9:5953. doi: 10.1038/s41598-019-42227-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42227-5</ArticleId><ArticleId IdType="pmc">PMC6459891</ArticleId><ArticleId IdType="pubmed">30976019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovel J, Patterson J, Wang W, Hotte N, O&#x2019;Keefe S, Mitchel T, et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol. 2016;7:459. doi: 10.3389/fmicb.2016.00459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00459</ArticleId><ArticleId IdType="pmc">PMC4837688</ArticleId><ArticleId IdType="pubmed">27148170</ArticleId></ArticleIdList></Reference><Reference><Citation>Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31:814&#x2013;821. doi: 10.1038/nbt.2676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2676</ArticleId><ArticleId IdType="pmc">PMC3819121</ArticleId><ArticleId IdType="pubmed">23975157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas-Lloret J, Ob&#xf3;n-Santacana M, Ib&#xe1;&#xf1;ez-Sanz G, Guin&#xf3; E, Pato ML, Rodriguez-Moranta F, et al. Gut microbiome diversity detected by high-coverage 16S and shotgun sequencing of paired stool and colon sample. Sci Data. 2020;7:92. doi: 10.1038/s41597-020-0427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-020-0427-5</ArticleId><ArticleId IdType="pmc">PMC7075950</ArticleId><ArticleId IdType="pubmed">32179734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilocca B, Pieroni L, Soggiu A, Britti D, Bonizzi L, Roncada P, et al. Gut&#x2013;brain axis and neurodegeneration: state-of-the-art of meta-omics sciences for microbiota characterization. Int J Mol Sci. 2020;21:4045. doi: 10.3390/ijms21114045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21114045</ArticleId><ArticleId IdType="pmc">PMC7312636</ArticleId><ArticleId IdType="pubmed">32516966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimermancic P, Medema MH, Claesen J, Kurita K, Wieland Brown LC, Mavrommatis K, et al. Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell. 2014;158:412&#x2013;421. doi: 10.1016/j.cell.2014.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.06.034</ArticleId><ArticleId IdType="pmc">PMC4123684</ArticleId><ArticleId IdType="pubmed">25036635</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O&#x2019;Connor G, et al. Neurotransmitters: the critical modulators regulating gut-brain axis. J Cell Physiol. 2017;232:2359&#x2013;2372. doi: 10.1002/jcp.25518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25518</ArticleId><ArticleId IdType="pmc">PMC5772764</ArticleId><ArticleId IdType="pubmed">27512962</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84&#x2013;96. doi: 10.1016/j.cell.2013.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.016</ArticleId><ArticleId IdType="pubmed">24412651</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20:145&#x2013;155. doi: 10.1038/nn.4476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4476</ArticleId><ArticleId IdType="pmc">PMC6960010</ArticleId><ArticleId IdType="pubmed">28092661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang R-F. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019;16:53. doi: 10.1186/s12974-019-1434-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1434-3</ArticleId><ArticleId IdType="pmc">PMC6397457</ArticleId><ArticleId IdType="pubmed">30823925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57:1&#x2013;24. doi: 10.1007/s00394-017-1445-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-017-1445-8</ArticleId><ArticleId IdType="pmc">PMC5847071</ArticleId><ArticleId IdType="pubmed">28393285</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajmalnik-Brown R, Ilhan Z-E, Kang D-W, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27:201&#x2013;214. doi: 10.1177/0884533611436116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533611436116</ArticleId><ArticleId IdType="pmc">PMC3601187</ArticleId><ArticleId IdType="pubmed">22367888</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson&#x2019;s disease. Nat Commun. 2019;10. 10.1038/s41467-019-08294-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338741</ArticleId><ArticleId IdType="pubmed">30659181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Zhang Y, Gong Y, Yang R, Chen Z, Hu W, et al. Sodium butyrate triggers a functional elongation of microglial process via Akt-small RhoGTPase activation and HDACs inhibition. Neurobiol Dis. 2018;111:12&#x2013;25. doi: 10.1016/j.nbd.2017.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.12.006</ArticleId><ArticleId IdType="pubmed">29248540</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman ML, Puig KL, Combs CK, Rosenberger TA. Acetate reduces microglia inflammatory signaling in vitro. J Neurochem. 2012;123:555&#x2013;567. doi: 10.1111/j.1471-4159.2012.07955.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07955.x</ArticleId><ArticleId IdType="pmc">PMC3472042</ArticleId><ArticleId IdType="pubmed">22924711</ArticleId></ArticleIdList></Reference><Reference><Citation>Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446&#x2013;450. doi: 10.1038/nature12721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12721</ArticleId><ArticleId IdType="pubmed">24226770</ArticleId></ArticleIdList></Reference><Reference><Citation>Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451&#x2013;455. doi: 10.1038/nature12726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12726</ArticleId><ArticleId IdType="pmc">PMC3869884</ArticleId><ArticleId IdType="pubmed">24226773</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman ML, Combs CK, Rosenberger TA. Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes. J NeuroImmune Pharmacol. 2013;8:287&#x2013;300. doi: 10.1007/s11481-012-9426-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-012-9426-4</ArticleId><ArticleId IdType="pmc">PMC3587660</ArticleId><ArticleId IdType="pubmed">23233245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Frenette PS. Cross talk between neutrophils and the microbiota. Blood. 2019;133:2168&#x2013;2177. doi: 10.1182/blood-2018-11-844555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-11-844555</ArticleId><ArticleId IdType="pmc">PMC6524562</ArticleId><ArticleId IdType="pubmed">30898860</ArticleId></ArticleIdList></Reference><Reference><Citation>Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, et al. Butyrate and trichostatin A attenuate nuclear factor &#x3ba;B activation and tumor necrosis factor &#x3b1; secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res. 2008;28:321&#x2013;328. doi: 10.1016/j.nutres.2008.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2008.02.012</ArticleId><ArticleId IdType="pubmed">19083427</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinolo MAR, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22:849&#x2013;855. doi: 10.1016/j.jnutbio.2010.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2010.07.009</ArticleId><ArticleId IdType="pubmed">21167700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22:586&#x2013;597. doi: 10.1038/nm.4106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4106</ArticleId><ArticleId IdType="pmc">PMC4899206</ArticleId><ArticleId IdType="pubmed">27158906</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriche GM, Almeida L, St&#xfc;ve P, Velasquez L, Dhillon-LaBrooy A, Roy U, et al. Regulating T-cell differentiation through the polyamine spermidine. J Allergy Clin Immunol. 2020. 10.1016/j.jaci.2020.04.037.</Citation></Reference><Reference><Citation>Zhang M, Wang H, Tracey KJ. Regulation of macrophage activation and inflammation by spermine: a new chapter in an old story. Crit Care Med. 2000;28(4 Suppl):N60&#x2013;N66. doi: 10.1097/00003246-200004001-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200004001-00007</ArticleId><ArticleId IdType="pubmed">10807317</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasperi V, Sibilano M, Savini I, Catani MV. Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci. 2019;20. 10.3390/ijms20040974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6412771</ArticleId><ArticleId IdType="pubmed">30813414</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539&#x2013;544. doi: 10.1126/science.aad9378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad9378</ArticleId><ArticleId IdType="pmc">PMC5050524</ArticleId><ArticleId IdType="pubmed">27126036</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121&#x2013;141. doi: 10.1016/j.cell.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Vangoitsenhoven R, Cresci GAM. Role of microbiome and antibiotics in autoimmune diseases. Nutr Clin Pract. 2020;35:406&#x2013;416. doi: 10.1002/ncp.10489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ncp.10489</ArticleId><ArticleId IdType="pubmed">32319703</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16:341&#x2013;352. doi: 10.1038/nri.2016.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.42</ArticleId><ArticleId IdType="pmc">PMC5541232</ArticleId><ArticleId IdType="pubmed">27231050</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W, Ao H, Peng C. Gut microbiota, short-chain fatty acids, and herbal medicines. Front Pharmacol. 2018;9. 10.3389/fphar.2018.01354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265305</ArticleId><ArticleId IdType="pubmed">30532706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrmann J, Effenberg L, Wilk C, Schoemer D, Phuong NNT, Adamczyk A, et al. Depletion of Foxp3 regulatory T cells is accompanied by an increase in the relative abundance of Firmicutes in the murine gut microbiome. Immunology. 2020;159:344&#x2013;353. doi: 10.1111/imm.13158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13158</ArticleId><ArticleId IdType="pmc">PMC7011623</ArticleId><ArticleId IdType="pubmed">31755554</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015;17:565&#x2013;576. doi: 10.1016/j.chom.2015.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.04.011</ArticleId><ArticleId IdType="pmc">PMC4442490</ArticleId><ArticleId IdType="pubmed">25974299</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D, Hrab&#x11b; de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965&#x2013;977. doi: 10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4030</ArticleId><ArticleId IdType="pmc">PMC5528863</ArticleId><ArticleId IdType="pubmed">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Green C, Altschuler G, Wei W, Bury JJ, Heath PR, et al. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2017;5:23. doi: 10.1186/s40478-017-0424-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0424-x</ArticleId><ArticleId IdType="pmc">PMC5353945</ArticleId><ArticleId IdType="pubmed">28302159</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S A. 2014;111:829&#x2013;832. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D&#x2019;Amico R, et al. FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front Neurol. 2019;10:1021. doi: 10.3389/fneur.2019.01021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01021</ArticleId><ArticleId IdType="pmc">PMC6763586</ArticleId><ArticleId IdType="pubmed">31620079</ArticleId></ArticleIdList></Reference><Reference><Citation>MIROCALS: Modifying Immune Response and OutComes in ALS - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03039673. Accessed 19 July 2020.</Citation></Reference><Reference><Citation>Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16:35&#x2013;56. doi: 10.1038/s41575-018-0061-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-018-0061-2</ArticleId><ArticleId IdType="pubmed">30262901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills M, Stanton L, Smith R. Precision Nutrition and the Microbiome, Part I: Current State of the Science. Nutrients. 2019;11:923. doi: 10.3390/nu11040923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11040923</ArticleId><ArticleId IdType="pmc">PMC6520976</ArticleId><ArticleId IdType="pubmed">31022973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214. doi: 10.1126/science.1241214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1241214</ArticleId><ArticleId IdType="pmc">PMC3829625</ArticleId><ArticleId IdType="pubmed">24009397</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027&#x2013;1031. doi: 10.1038/nature05414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05414</ArticleId><ArticleId IdType="pubmed">17183312</ArticleId></ArticleIdList></Reference><Reference><Citation>Stambler N, Charatan M, Cedarbaum JM, ALS CNTF Treatment Study Group*. Prognostic indicators of survival in ALS. Neurology. 1998;50:66&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">9443459</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570:462&#x2013;467. doi: 10.1038/s41586-019-1291-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1291-3</ArticleId><ArticleId IdType="pmc">PMC6597290</ArticleId><ArticleId IdType="pubmed">31158845</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld GJ, van Kan HJM, Sastre Tora&#xf1;o J, Veldink JH, Guchelaar H-J, Wokke JHJ, et al. Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS. J Neurol Sci. 2001;191:121&#x2013;125. doi: 10.1016/s0022-510x(01)00613-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(01)00613-x</ArticleId><ArticleId IdType="pubmed">11677002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarate CA, Manji HK. Riluzole in psychiatry: a systematic review of the literature. Expert Opin Drug Metab Toxicol. 2008;4:1223&#x2013;1234. doi: 10.1517/17425255.4.9.1223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.4.9.1223</ArticleId><ArticleId IdType="pmc">PMC2587133</ArticleId><ArticleId IdType="pubmed">18721116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach G, Schellekens H, Dinan TG, Cryan JF. Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics. 2018;15:36&#x2013;59. doi: 10.1007/s13311-017-0585-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0585-0</ArticleId><ArticleId IdType="pmc">PMC5794698</ArticleId><ArticleId IdType="pubmed">29134359</ArticleId></ArticleIdList></Reference><Reference><Citation>Karl JP, Hatch AM, Arcidiacono SM, Pearce SC, Pantoja-Feliciano IG, Doherty LA, et al. Effects of psychological, environmental and physical stressors on the gut microbiota. Front Microbiol. 2018;9:2013. doi: 10.3389/fmicb.2018.02013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02013</ArticleId><ArticleId IdType="pmc">PMC6143810</ArticleId><ArticleId IdType="pubmed">30258412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung SG, Goldenthal AR, Uhlemann A-C, Mann JJ, Miller JM, Sublette ME. Systematic review of gut microbiota and major depression. Front Psychiatry. 2019;10:34. doi: 10.3389/fpsyt.2019.00034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2019.00034</ArticleId><ArticleId IdType="pmc">PMC6378305</ArticleId><ArticleId IdType="pubmed">30804820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CE, McVey AL, Rudnicki S, Dimachkie MM, Barohn RJ. Symptom management and end-of-life care in amyotrophic lateral sclerosis. Neurol Clin. 2015;33:889&#x2013;908. doi: 10.1016/j.ncl.2015.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.010</ArticleId><ArticleId IdType="pmc">PMC5031364</ArticleId><ArticleId IdType="pubmed">26515628</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahamsson H, Ostlund-Lindqvist A-M, Nilsson R, Simr&#xe9;n M, Gillberg P-G. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol. 2008;43:1483&#x2013;1488. doi: 10.1080/00365520802321212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365520802321212</ArticleId><ArticleId IdType="pubmed">18788050</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima T. Contractile effect of short-chain fatty acids on the isolated colon of the rat. J Physiol. 1985;368:667&#x2013;678. doi: 10.1113/jphysiol.1985.sp015882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1985.sp015882</ArticleId><ArticleId IdType="pmc">PMC1192621</ArticleId><ArticleId IdType="pubmed">2867220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang M, Shang W, Ma Q, Strappe P, Zhou Z. Abundance of probiotics and butyrate-production microbiome manages constipation via short-chain fatty acids production and hormones secretion. Mol Nutr Food Res. 2019;63:1801187. doi: 10.1002/mnfr.201801187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201801187</ArticleId><ArticleId IdType="pubmed">31556210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel M, Lin HC, Enayati P, van den Burg B, Lee H-R, Chen JH, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1089&#x2013;G1095. doi: 10.1152/ajpgi.00574.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00574.2004</ArticleId><ArticleId IdType="pubmed">16293652</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathy G, Chen J, Chen X, Chia N, O&#x2019;Connor HM, Wolf PG, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology. 2016;150:367&#x2013;79.e1. doi: 10.1053/j.gastro.2015.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2015.10.005</ArticleId><ArticleId IdType="pmc">PMC4727996</ArticleId><ArticleId IdType="pubmed">26460205</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2016;12:526&#x2013;538. doi: 10.1038/nrneurol.2016.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.111</ArticleId><ArticleId IdType="pubmed">27514291</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210&#x2013;215. doi: 10.1038/nature25973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25973</ArticleId><ArticleId IdType="pubmed">29489753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>